Informations générales (source: ClinicalTrials.gov)

NCT02892526 Statut inconnu
Wound Vitality Markers in Forensic Pathology (PLAIES VITALES)
Observational
  • Plaies et blessures
Central Hospital, Nancy, France (Voir sur ClinicalTrials)
décembre 2014
décembre 2016
29 juin 2024
The purpose is to determine intrinsic properties of various immunohistochemical markers (FVIIIra, CD15, CD30, tryptase, TNFα, IL-1β, TGFα et TGFβ1) for diagnosis of vital wound, alone and in association (evaluation of sensibility with surgery wounds and evaluation of specificity with post-mortem wounds). Secondary purposes are to measure the minimum time to obtain a positive labeling in vital wounds, and to evaluate inter-observer reproducibility of vitality diagnosis with different markers. Expression of microRNA miR 9, miR 21 et miR 198 will be also studied.

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CHRU Nancy - Nancy - France En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

Alive persons:

- Abdominoplasty

Deceased persons:

- Medico-scientific autopsy for diagnosis



Alive persons:

- Fragmented sample with non-visible banks

- Cutaneous pathology

Deceased persons:

- Persons under protection

- Medico-legal obstacle

- Cutaneous pathology